The development of a common childhood respiratory virus experimental vaccines

Universal message

Washington on November 1 (xinhua) & have spent U.S. and Chinese researchers in 1, published in the journal science reports that they are to develop an experimental vaccine, can prevent the most common childhood respiratory virus, respiratory syncytial virus (RSV).

respiratory syncytial virus is a kind of infectious virus, can lead to pneumonia is the main cause of hospitalization in children under the age of five. Globally, the respiratory syncytial virus is after malaria infants and young children under the age of 1, the second largest killer. Although medical experts has more than 40 years in the research on the virus, but always failed to develop effective vaccines.

and the national institute of allergy and infectious diseases of xiamen university in China, the researchers had previously found together an antibody that can keep respiratory syncytial virus surface membrane protein F an unstable of the key structure, efficiently and inhibition of respiratory syncytial virus infection.